Skip to main content
. 2022 Oct 11;10(10):1693. doi: 10.3390/vaccines10101693

Figure 1.

Figure 1

Figure 1

Figure 1(A–C). Anti-RBD antibodies titer of individual participants, before and after vaccine in different subgroups of renal allograft recipients. 1(D). Anti RBD antibodies titer in groups of renal transplant recipients with symptomatic or asymptomatic prior Covid infection.